Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
-8.8%/yr
vs -19.6%/yr prior
5Y CAGR
-11.8%/yr
Consistent
Acceleration
+10.8pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
7 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $65.32M | -3.4% |
| 2024 | $67.64M | -14.6% |
| 2023 | $79.20M | -8.1% |
| 2022 | $86.16M | -11.2% |
| 2021 | $97.07M | -20.7% |
| 2020 | $122.47M | -40.3% |
| 2019 | $205.20M | -0.7% |
| 2018 | $206.63M | +101.0% |
| 2017 | $102.81M | +16.5% |
| 2016 | $88.27M | - |